Proteomic discovery in diabetic kidney disease-to what end?
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 35870813.
- Also identified by DOI 10.1016/j.kint.2022.05.013.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Emerging approaches that enable high-throughput analysis of the plasma proteome have been increasingly deployed in nephrology research. Kobayashi et al. provide a valuable addition to this literature, describing an untargeted proteomic analysis of diabetic kidney disease progression to end-stage kidney disease. This commentary places the study's findings in the context of the broader literature and outlines potential avenues toward biological insight and clinical utility.
Medical subject headings
- Diabetes Mellitus
- Diabetic Nephropathies
- Nephrology